GB Patent

GB2573784A — A stable aqueous hydroxycarbamide solution

Assigned to Nova Bio Pharma Product Dev Ltd · Expires 2019-11-20 · 6y expired

What this patent protects

A stable aqueous hydroxycarbamide solution comprising: hydroxycarbamide; a pH adjuster being one of sodium hydroxide, potassium hydroxide, sodium bicarbonate, and sodium carbonate, or a mixture of one or more of these substances; wherein: the solution is controlled to have a pH o…

USPTO Abstract

A stable aqueous hydroxycarbamide solution comprising: hydroxycarbamide; a pH adjuster being one of sodium hydroxide, potassium hydroxide, sodium bicarbonate, and sodium carbonate, or a mixture of one or more of these substances; wherein: the solution is controlled to have a pH of between 6.1 and 7.1 is provided. The pH adjuster is preferably sodium hydroxide. Said stable aqueous hydroxycarbamide solution may further contain a preservative, a viscosity modifying agent, a sweetener and a flavouring agent. The preservative is selected from a base of methyl, ethyl, propyl or butyl hydroxybenzoate. The sweetener may be sucralose, aspartame or acesulfame K and the viscosity modifying agent may be xanthan gum. Said stable aqueous hydroxycarbamide solution for use in the treatment of sickle cell disease is provided.

Drugs covered by this patent

Patent Metadata

Patent number
GB2573784A
Jurisdiction
GB
Classification
Expires
2019-11-20
Drug substance claim
No
Drug product claim
No
Assignee
Nova Bio Pharma Product Dev Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.